沙特阿拉伯王国政府所属的官方政府网站。
周四 25 6月 2026
沙特官方政府网站的域名以下列后缀结尾 gov.sa
沙特阿拉伯王国所有政府机构的官方网站均以 .gov.sa 结尾。
政府网站使用以下协议。 HTTPS 用于加密和安全。
沙特阿拉伯王国所有政府机构的官方网站均以 .gov.sa 结尾。
SFDA Alerts : ‘ VICTOZA’ drug should only be used under prescription and for Type 2 –Diabetic patients
2019-07-08
H.E SFDA Vice President for Drug Sector, Dr. Saleh Bawazir confirmed that ‘VICTOZA’ product, with the scientific name ‘LERAGLUTIDE’ is registered in SFDA under No. 11-100-59 since 1432H and a number of shipments of this product were released in the Kingdom, and therefore it is available, on the contrary of what is claimed by various media systems.
Dr. Bawazir explained that “VICTOZA’ product is only used for type 2 diabetes and is not used as first-line therapy as indicated in the notice to health practitioners, issued by the manufacturer” He emphasized that this drug should only be prescribed by endocrine specialists in hospitals, as it has many side effects e,g. acute pancreas infection and thyroid gland cancer.
He added, it was the manufacturer’s duty, from the professional perspective, to address the plans for reducing the risks of this product which were approved by SFDA, including distribution of instructions for use to patients.
Warning date
2014-06-08
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。